Kim et al., demonstrated that TXA can reduce melanin content by decreasing tyrosinase activity and the expression of melanogenesis-related enzymes (tyrosinase, TRP-1 and TRP-2) in melanocytes and melanoma cells [110]. The gene discussed is DCT; the disease is melanoma.